Biotechnology uses in the development of personalized medicine
Keywords:
personalized medicine, biotechnology, omics.Abstract
The modern biotechnology, developed starting from a wide range of technologies, has been motivated by the necessity of acquiring new medical treatments, which offers exceptional contributions to the human medicine and favors the advance of the science whose progress establishes the step toward the denominated personalized medicine. To such effects an exhaustive review on the uses of the biotechnology was carried out by means of the diverse omics technologies employment (genomics, proteomics and pharmacogenomics, among others).
Downloads
Download data is not yet available.
References
1. Introducción a la Biotecnología. La Habana: Universidad para todos; 1998.
2. Sasson A. Biotecnología: desafíos y promesas. La Habana: UNESCO/Centro de Investigaciones Biológicas;1985. p: 175.
3. Medrano Hernández AM. Medicina personalizada: hacia un nuevo modelo en la práctica médica. Arch Neurocien (Mex). 2012;17(2): 129-31.
4. Andreu AL. La medicina personalizada: una nueva forma de entender la medicina [citado 12 Ago 2015]. Disponible en: http://cedimcat.info/images/web/contenido/profesionales/farmacoterapia/medicinapersonalitzada_gener2013_cast.pdf
5. Hood L, Heath JR, Phelps ME, Lin B. System’s biology and new technologies enable predictive and preventative medicine. Science. 2004 [12 Ago 2015]; 306: 640-3. Disponible en: http://science.sciencemag.org/content/306/5696/640
6. Lifshitz A. La medicina personalizada no es solo farmacogenómica. Med Int Mex. 2009;25(5):335-6.
7. Medicina genómica: hacia una medicina personalizada, 2004 [12 Ago 2015]. Disponible en: http://www.revistabioanalisis.com/arxius/notas/nota3_31.pdf
8. Jiménez Sánchez G. La medicina genómica: el inicio de una nueva era en la práctica médica 2004 [citado 12 Ago 2015]. Disponible en: http://webcache.googleusercontent.com/search?q=cache:I6AXhhL6DLQJ:salud.cibercuba.com/node/1328&num=1&hl=es&strip=1&vwsrc=0
9. Chadwell, K. Clinical practice on the horizon: personalized medicine. Clin Nurse Spec. 2013; 27(1):36-43.
10. Conti R, Veenstra DL, Armstrong K, Lesko LJ, Grosse SD. Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness and future research priorities. Med Decis Making. 2010; 30(3): 328–40.
11. Auffray C, Chen Z, Hood L. Systems medicine: the future of medical genomics and healthcare. Genome. 2009; 1:2.
12. Spalvieri MP, Rotenberg RG. Medicina genómica. Aplicaciones del polimorfismo de un nucleótido y micromatrices de ADN. Medicina (B. Aires). 2004 [citado 12 Ago 2015];64(6). Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802004000600011
13. Wylie Burke, MD PhD, Susan Brown Trinidad, MA, and Nancy A Press, PhD. Essential Elements of Personalized Medicine. Urol Oncol. 2014; 32(2):193-7.
14. Kenneth Offit. Personalized medicine: new genomics, old lessons. Hum Genet. 2011; 130(1): 3–14.
15. Ginsburg GS, Willard HF. Genomic and personalized medicine: foundations and applications. Transl Res. 2009; 154 (6):277-87.
16. Hong KW, Oh B. Overview of personalized medicine in the disease genomic era. BMB Rep. 2010; 43(10):643-8.
17. Weston AD, Hood L. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J Proteome Res. 2004; 3: 179-96.
18. Tremblay J, Hamet P. Role of genomics on the path to personalized medicine. Metabolism. 2013; 62 (Suppl 1):2-5.
19. Kalia M. Biomarkers for personalized oncology: recent advances and future challenges. Metabolism. 2015 [citado 12 ago 2015]; 64(3 Suppl 1): 16-21. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25468140
20. Mukesh Verma. Personalized medicine and cancer. J Pers Med. 2012;2(1):1-14.
21. Kalia M. Personalized oncology: recent advances and future challenges. Metabolism. 2013 [citado 12 ago 2015]; 62 (Suppl 1):11-4. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22999010
22. Castellanos L, González LJ, Padrón G. Proteómica médica [12 Ago 2015]. Disponible en: http://elfosscientiae.cigb.edu.cu/PDFs/Muestras/chapter20.pdf
23. Pando Robles RV, Lanz Mendoza H. La importancia de la proteómica en la salud pública. Salud Pública Méx. 2009;51(sup 3):386-94.
24. Malik NN. Drug discovery: past, present and future. Drug Discov Today. 2008; 13 (21-22): 909-12.
25. Pene F, Courtine E, Cariou A, Mira JP. Toward theragnostics. Crit Care Med. 2009; 37(Suppl 1): 50-8.
26. Rodríguez Antona C, Taron M. Pharmacogenomic biomarkers for personalized cancer treatment. J. Intern Med. 2015 [citado 12 Ago 2015]; 277(2): 201-17. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25338550
27. Grüllich C, von Kalle C. Recent developments and future perspectives of personalized oncology. Onkologie. 2012;35(Suppl 1):4-7.
28. Snyderman R. Personalized health care: from theory to practice. Biotechnol J. 2012; 7(8):1-7.
29. Wolf Dieter L. Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology. Z Evid Forbild Qual Gesundhwes. 2012;106(1):11-22.
30. Ruiz García JA. Aspectos jurídicos de la medicina personalizada. InDret. 2005 [citado 12 Ago 2015];2. Disponible en: http://www.raco.cat/index.php/InDret/article/view/79579/103787
31. Lisker R. Medicina genómica. Mitos y realidades. Rev Invest Clin. 2004; 56(4): 554-60.
32. Snyderman R. Personalized health care in 2013: a status report on the impact of genomics. N C Med J. 2013; 74(6): 478-84.
33. Isaza C, Sepúlveda Arias J, Henao J. La farmacogenómica en medicina. Colomb Med. 2009 [citado 12 Ago 2015];40(3). Disponible en: (http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S1657-95342009000300010
34. Verma M. Personalized Medicine and Cancer J Pers Med. 2012; 2(1):1–14.
35. Hu R, Wang X, Zhan X. Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer. EPMA J. 2013 [citado 12 Ago 2015]; 4(1): 2. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564825/
36. Lesk A. Introduction to bioinformatics. 4th ed. Londres: Oxford University; 2013.
37. Cruz Pinzón A. Metabolómica aplicada al diagnóstico preimplantacional no invasivo [citado 12 Ago 2015]. Disponible en: http://www.monografias.com/trabajos82/metabolomica-aplicada/metabolomica-aplicada.shtml
38. Hernández Betancourt JC, Serrano Barrera O. La medicina personalizada, la revolución genómica y el sistema nacional de salud. Rev Cubana Salud Pública. 2014 [citado 12 Ago 2015]; 40(4). Disponible en: http://www.bvs.sld.cu/revistas/spu/vol40_4_14/spu12414.htm
39. Barrios López Y, Perera Fernández F, Carvajal Beltrán II, Pérez Rodríguez A. Pesquisa de cáncer de próstata en 8 áreas de salud de la provincia de Santiago de Cuba. MEDISAN. 2012 [citado 12 Ago 2015];16(3):376-82. Disponible en: http://bvs.sld.cu/revistas/san/vol_16_3_12/san10312.htm
2. Sasson A. Biotecnología: desafíos y promesas. La Habana: UNESCO/Centro de Investigaciones Biológicas;1985. p: 175.
3. Medrano Hernández AM. Medicina personalizada: hacia un nuevo modelo en la práctica médica. Arch Neurocien (Mex). 2012;17(2): 129-31.
4. Andreu AL. La medicina personalizada: una nueva forma de entender la medicina [citado 12 Ago 2015]. Disponible en: http://cedimcat.info/images/web/contenido/profesionales/farmacoterapia/medicinapersonalitzada_gener2013_cast.pdf
5. Hood L, Heath JR, Phelps ME, Lin B. System’s biology and new technologies enable predictive and preventative medicine. Science. 2004 [12 Ago 2015]; 306: 640-3. Disponible en: http://science.sciencemag.org/content/306/5696/640
6. Lifshitz A. La medicina personalizada no es solo farmacogenómica. Med Int Mex. 2009;25(5):335-6.
7. Medicina genómica: hacia una medicina personalizada, 2004 [12 Ago 2015]. Disponible en: http://www.revistabioanalisis.com/arxius/notas/nota3_31.pdf
8. Jiménez Sánchez G. La medicina genómica: el inicio de una nueva era en la práctica médica 2004 [citado 12 Ago 2015]. Disponible en: http://webcache.googleusercontent.com/search?q=cache:I6AXhhL6DLQJ:salud.cibercuba.com/node/1328&num=1&hl=es&strip=1&vwsrc=0
9. Chadwell, K. Clinical practice on the horizon: personalized medicine. Clin Nurse Spec. 2013; 27(1):36-43.
10. Conti R, Veenstra DL, Armstrong K, Lesko LJ, Grosse SD. Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness and future research priorities. Med Decis Making. 2010; 30(3): 328–40.
11. Auffray C, Chen Z, Hood L. Systems medicine: the future of medical genomics and healthcare. Genome. 2009; 1:2.
12. Spalvieri MP, Rotenberg RG. Medicina genómica. Aplicaciones del polimorfismo de un nucleótido y micromatrices de ADN. Medicina (B. Aires). 2004 [citado 12 Ago 2015];64(6). Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802004000600011
13. Wylie Burke, MD PhD, Susan Brown Trinidad, MA, and Nancy A Press, PhD. Essential Elements of Personalized Medicine. Urol Oncol. 2014; 32(2):193-7.
14. Kenneth Offit. Personalized medicine: new genomics, old lessons. Hum Genet. 2011; 130(1): 3–14.
15. Ginsburg GS, Willard HF. Genomic and personalized medicine: foundations and applications. Transl Res. 2009; 154 (6):277-87.
16. Hong KW, Oh B. Overview of personalized medicine in the disease genomic era. BMB Rep. 2010; 43(10):643-8.
17. Weston AD, Hood L. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J Proteome Res. 2004; 3: 179-96.
18. Tremblay J, Hamet P. Role of genomics on the path to personalized medicine. Metabolism. 2013; 62 (Suppl 1):2-5.
19. Kalia M. Biomarkers for personalized oncology: recent advances and future challenges. Metabolism. 2015 [citado 12 ago 2015]; 64(3 Suppl 1): 16-21. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25468140
20. Mukesh Verma. Personalized medicine and cancer. J Pers Med. 2012;2(1):1-14.
21. Kalia M. Personalized oncology: recent advances and future challenges. Metabolism. 2013 [citado 12 ago 2015]; 62 (Suppl 1):11-4. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22999010
22. Castellanos L, González LJ, Padrón G. Proteómica médica [12 Ago 2015]. Disponible en: http://elfosscientiae.cigb.edu.cu/PDFs/Muestras/chapter20.pdf
23. Pando Robles RV, Lanz Mendoza H. La importancia de la proteómica en la salud pública. Salud Pública Méx. 2009;51(sup 3):386-94.
24. Malik NN. Drug discovery: past, present and future. Drug Discov Today. 2008; 13 (21-22): 909-12.
25. Pene F, Courtine E, Cariou A, Mira JP. Toward theragnostics. Crit Care Med. 2009; 37(Suppl 1): 50-8.
26. Rodríguez Antona C, Taron M. Pharmacogenomic biomarkers for personalized cancer treatment. J. Intern Med. 2015 [citado 12 Ago 2015]; 277(2): 201-17. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25338550
27. Grüllich C, von Kalle C. Recent developments and future perspectives of personalized oncology. Onkologie. 2012;35(Suppl 1):4-7.
28. Snyderman R. Personalized health care: from theory to practice. Biotechnol J. 2012; 7(8):1-7.
29. Wolf Dieter L. Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology. Z Evid Forbild Qual Gesundhwes. 2012;106(1):11-22.
30. Ruiz García JA. Aspectos jurídicos de la medicina personalizada. InDret. 2005 [citado 12 Ago 2015];2. Disponible en: http://www.raco.cat/index.php/InDret/article/view/79579/103787
31. Lisker R. Medicina genómica. Mitos y realidades. Rev Invest Clin. 2004; 56(4): 554-60.
32. Snyderman R. Personalized health care in 2013: a status report on the impact of genomics. N C Med J. 2013; 74(6): 478-84.
33. Isaza C, Sepúlveda Arias J, Henao J. La farmacogenómica en medicina. Colomb Med. 2009 [citado 12 Ago 2015];40(3). Disponible en: (http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S1657-95342009000300010
34. Verma M. Personalized Medicine and Cancer J Pers Med. 2012; 2(1):1–14.
35. Hu R, Wang X, Zhan X. Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer. EPMA J. 2013 [citado 12 Ago 2015]; 4(1): 2. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564825/
36. Lesk A. Introduction to bioinformatics. 4th ed. Londres: Oxford University; 2013.
37. Cruz Pinzón A. Metabolómica aplicada al diagnóstico preimplantacional no invasivo [citado 12 Ago 2015]. Disponible en: http://www.monografias.com/trabajos82/metabolomica-aplicada/metabolomica-aplicada.shtml
38. Hernández Betancourt JC, Serrano Barrera O. La medicina personalizada, la revolución genómica y el sistema nacional de salud. Rev Cubana Salud Pública. 2014 [citado 12 Ago 2015]; 40(4). Disponible en: http://www.bvs.sld.cu/revistas/spu/vol40_4_14/spu12414.htm
39. Barrios López Y, Perera Fernández F, Carvajal Beltrán II, Pérez Rodríguez A. Pesquisa de cáncer de próstata en 8 áreas de salud de la provincia de Santiago de Cuba. MEDISAN. 2012 [citado 12 Ago 2015];16(3):376-82. Disponible en: http://bvs.sld.cu/revistas/san/vol_16_3_12/san10312.htm
Published
2016-05-07
How to Cite
1.
Díaz Fernández U, Rodríguez Ferreiro AO. Biotechnology uses in the development of personalized medicine. MEDISAN [Internet]. 2016 May 7 [cited 2025 Jun. 2];20(5). Available from: https://medisan.sld.cu/index.php/san/article/view/764
Issue
Section
Review articles
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
![Secimed](/templates/images/secimed.png"){kind=small}
Guidelines for authors
